Pharmaceuticals
US FDA approves Trulance for Chronic Idiopathic Constipation

US FDA approves Trulance for Chronic Idiopathic Constipation

Washington: The US Food and Drug Administration has approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients. more

Paediatrician suspended from IAP after raising voice against ‘nexus’ between vaccine manufacturers and doctors

Paediatrician suspended from IAP after raising voice against ‘nexus’ between vaccine manufacturers and doctors

Bengaluru: Dr Vipin Vashishtha, a paediatrician who wrote on December 17 last year to all 24,000 members of the Indian Academy of Paediatrics (IAP) raising concerns over immunization guidelines being allegedly tweaked to favour certain vaccine manufacturers, was on Friday suspended from all memberships of the association, including as convener of the Advisory Committee on Vaccines and Immunisation Practices. more

PerkinElmer inks agreement to acquire Tulip Diagnostics

PerkinElmer inks agreement to acquire Tulip Diagnostics

Goa: US-based PerkinElmer has entered into an agreement to acquire Tulip Diagnostics, one of India’s largest domestic providers of in-vitro diagnostic reagents, kits and instruments. Goa-based Tulip Diagnostics has more than 1,200 full-time employees. more

US FDA approves first drug for spinal muscular atrophy

US FDA approves first drug for spinal muscular atrophy

Washington: The US Food and Drug Administration on Friday approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement. Spinraza is an injection administered into the fluid surrounding the spinal cord. more

Doctors cautioned over adverse effects of 24 drugs

Doctors cautioned over adverse effects of 24 drugs

New Delhi: Indian Pharmacopoeia Commission (IPC) has named 24 drugs that have adverse reactions and that doctors must therefore prescribe with caution. more

US FDA grants approval to new treatment for advanced ovarian cancer

US FDA grants approval to new treatment for advanced ovarian cancer

Washington: The US Food and Drug Administration on Monday granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer. more

US FDA approves Eucrisa for eczema

US FDA approves Eucrisa for eczema

Washington: The US Food and Drug Administration on Wednesday approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older. more

Pfizer, Flynn Pharma fined £90 million for increasing epilepsy drug price by 2600%

Pfizer, Flynn Pharma fined £90 million for increasing epilepsy drug price by 2600%

London: UK’s primary competition and consumer authority, the Competition and Markets Authority (CMA), has imposed a record £84.2 million fine on the pharmaceutical manufacturer Pfizer, and a £5.2 million fine on the distributor Flynn Pharma after finding that each broke competition law by charging excessive and unfair prices in the UK for phenytoin sodium capsules, an anti-epilepsy drug. The CMA has also ordered the companies to reduce their prices. more

US FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes

US FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes

Washington: The US Food & Drug Administration has approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease. more

Abhay Gandhi appointed as interim CEO of Taro Pharmaceutical

Abhay Gandhi appointed as interim CEO of Taro Pharmaceutical

New York: Taro Pharmaceutical Industries, a subsidiary of Sun Pharmaceutical, on Thursday announced that its board of directors has appointed Abhay Gandhi as interim chief executive officer, effective January 1, 2017. more